9,10-dimethyl-1,2-benzanthracene has been researched along with Cancer of Eye in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bubeck, B; Eisenhut, M; Heimke, U; zum Winkel, K | 1 |
| Berg, RJ; Capel, PJ; de Gruijl, FR; de Vries, A; Dortant, PM; Hofhuis, FM; van Kreijl, CF; van Oostrom, CT; van Steeg, H; Verbeek, SJ; Wester, PW | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and Cancer of Eye
| Article | Year |
|---|---|
Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoquinolines; Animals; Cricetinae; Eye Neoplasms; Iodine Radioisotopes; Male; Melanoma; Mesocricetus; Methyltyrosines; Neoplasm Transplantation; Neoplasms, Experimental; Radionuclide Imaging; Skin Neoplasms; Tissue Distribution | 1981 |
Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cells, Cultured; DNA Repair; DNA-Binding Proteins; Eye Neoplasms; Gene Deletion; Gene Targeting; Genetic Predisposition to Disease; Humans; Mice; Mice, Inbred C57BL; Neoplasms, Radiation-Induced; Radiation Tolerance; Skin Neoplasms; Ultraviolet Rays; Xeroderma Pigmentosum; Xeroderma Pigmentosum Group A Protein | 1995 |